Rossari Biotech Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹684.86 crore, reflecting a quarter-on-quarter *(QoQ) increase of 17.74 per cent from ₹581.68 crore. This corresponds to a year-on-year *(YoY) growth of 18.17 per cent.
Operating Profit
Operating Profit stands at ₹77.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.17 per cent from ₹68.87 crore. This corresponds to a year-on-year *(YoY) growth of 11.17 per cent.
PBDT
PBDT stands at ₹87.78 crore, reflecting a quarter-on-quarter *(QoQ) increase of 41.33 per cent from ₹62.11 crore. This corresponds to a year-on-year *(YoY) growth of 33.16 per cent.
Profit Before Tax
Profit Before Tax stands at ₹64.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 51.18 per cent from ₹42.50 crore. This corresponds to a year-on-year *(YoY) growth of 34.70 per cent.
Net Profit
Net Profit stands at ₹45.97 crore, reflecting a quarter-on-quarter *(QoQ) increase of 40.28 per cent from ₹32.77 crore. This represents a 33.48 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Rossari Biotech Ltd News
Rossari Biotech Ltd Earnings
- YOY
- QOQ
Rossari Biotech Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Rossari Biotech Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Rossari Biotech Ltd Financial Reports
Rossari Biotech Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Rossari Biotech | -3.08% | -2.40% | 0.74% | 14.21% | -8.68% | -24.03% |
| NOCIL | -2.94% | -1.26% | 13.22% | 7.10% | 20.20% | -8.95% |
| Tatva Chintan | -1.11% | 4.58% | 9.08% | 3.38% | -3.11% | 30.56% |
| DDev Plastiks | -0.71% | 2.81% | 13.65% | 25.51% | -7.36% | 6.49% |
| Apcotex Industri | -1.44% | -0.81% | -2.53% | 32.13% | 42.19% | 25.51% |
| Camlin Fine | 1.58% | 2.12% | 5.77% | 23.00% | -12.84% | -54.84% |
| Veedol Corporat | 0.86% | 2.27% | 1.59% | 6.56% | -7.68% | -12.99% |
Company Info
Company Information
Chairman/ED & CEO : Edward Menezes
ED / MD / Promoter : Sunil Chari
Independent Non Exe. Director : Aseem Dhru
Independent Non Exe. Director : Esha Achan
Independent Non Exe. Director : GURUDAS VISHWAS ARAS
Independent Director : Udey Paul Singh Gill
CS / Compliance Officer / Legal Head : PARUL GUPTA